Naftifine Hydrochloride Gel
NDC Package 51672-1376-3
Package Information
Naftifine Hydrochloride gel is uSP, 2% is indicated for the treatment of interdigital tinea pedis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum. This formulation utilizes a gel delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-1376 and is authorized under FDA application ANDA208201.
Identification & Billing
- RxCUI: 1433734 - naftifine HCl 2 % Topical Gel
- RxCUI: 1433734 - naftifine hydrochloride 0.02 MG/MG Topical Gel
- RxCUI: 1433734 - naftifine hydrochloride 2 % Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-1376 - Naftifine Hydrochloride
- 51672-1376-3 - 1 TUBE in 1 CARTON / 60 g in 1 TUBE
- 51672-1376 - Naftifine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-1376). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-1376-3 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Naftifine Hydrochloride, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This gel is formulated for topical use and contains naftifine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on April 01, 2023. The current certification is valid through December 31, 2027.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672137603. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.